×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NASDAQ:KZR

Kezar Life Sciences Earnings Date, Estimates & Call Transcripts (2022)

$9.29
+1.02 (+12.33%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$8.10
$9.50
50-Day Range
$4.58
$13.94
52-Week Range
$4.30
$18.55
Volume
3.71 million shs
Average Volume
1.48 million shs
Market Capitalization
$561.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.67

Earnings Summary

Upcoming
Earnings Date
Aug. 11Estimated
Actual EPS
(May. 12)
-$0.26 Beat By $0.03
Consensus EPS
(May. 12)
-$0.29
Last Year's Q2 EPS
(5/12/2021)
-$0.25
Skip Charts & View Estimated and Actual Earnings Data

KZR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KZR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Kezar Life Sciences Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20221($0.27)($0.27)($0.27)
Q2 20222($0.30)($0.28)($0.29)
Q3 20222($0.26)($0.26)($0.26)
Q4 20222($0.27)($0.25)($0.26)
FY 20227($1.10)($1.06)($1.08)
Q1 20231($0.26)($0.26)($0.26)
Q2 20231($0.26)($0.26)($0.26)
Q3 20231($0.24)($0.24)($0.24)
Q4 20231($0.24)($0.24)($0.24)
FY 20234($1.00)($1.00)($1.00)

KZR Earnings Date and Information

Kezar Life Sciences last released its quarterly earnings results on May 12th, 2022. The reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.03. Kezar Life Sciences has generated ($1.04) earnings per share over the last year (($1.04) diluted earnings per share). Earnings for Kezar Life Sciences are expected to grow in the coming year, from ($1.19) to ($1.18) per share. Kezar Life Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off prior year's report dates.

Kezar Life Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/11/2022
(Estimated)
        
5/12/2022Q1 2022($0.29)($0.26)+$0.03($0.26)    
3/17/2022Q4 2021($0.29)($0.25)+$0.04($0.25)
11/9/20219/30/2021($0.26)($0.28)($0.02)($0.28)
8/12/20216/30/2021($0.26)($0.25)+$0.01($0.25)
5/12/20213/31/2021($0.24)($0.25)($0.01)($0.25)
3/11/202112/31/2020($0.23)($0.22)+$0.01($0.22)
11/5/2020Q3 2020($0.21)($0.23)($0.02)($0.23)  
8/5/2020Q2 2020($0.26)($0.22)+$0.04($0.22)  
5/7/2020Q1 2020($0.3740)($0.30)+$0.0740($0.30)
3/12/2020Q4 2019($0.5450)($0.500939)+$0.044061($0.50)
11/6/2019Q3($0.5140)($0.48)+$0.0340($0.48)
8/7/2019Q2 2019($0.4760)($0.46)+$0.0160($0.46)
5/7/2019Q1 2019($0.40)($0.40)($0.40)
3/26/201912/31/2018($0.36)($0.30)+$0.06($0.30)
11/8/20189/30/2018($0.48)($0.30)+$0.18($0.30)
8/9/2018Q2 2018($0.5430)($3.31)($2.7670)($3.31)












Kezar Life Sciences Earnings - Frequently Asked Questions

When is Kezar Life Sciences's earnings date?

Kezar Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off last year's report dates. Learn more on KZR's earnings history.

Did Kezar Life Sciences beat their earnings estimates last quarter?

In the previous quarter, Kezar Life Sciences (NASDAQ:KZR) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.29) by $0.03. Learn more on analysts' earnings estimate vs. KZR's actual earnings.

How can I listen to Kezar Life Sciences's earnings conference call?

The conference call for Kezar Life Sciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Kezar Life Sciences's conference call transcript?

The conference call transcript for Kezar Life Sciences's latest earnings report can be read online. Read Transcript

How much profit does Kezar Life Sciences generate each year?

Kezar Life Sciences (NASDAQ:KZR) has a recorded net income of -$54.63 million. KZR has generated -$1.04 earnings per share over the last four quarters.

What is Kezar Life Sciences's EPS forecast for next year?

Kezar Life Sciences's earnings are expected to grow from ($1.19) per share to ($1.18) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:KZR) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.